Carregant...

Persistent Diffusion-Restricted Lesions in Bevacizumab-Treated Malignant Gliomas Are Associated with Improved Survival Compared with Matched Controls

BACKGROUND AND PURPOSE: A subset of patients with malignant glioma develops conspicuous lesions characterized by persistent restricted diffusion during treatment with bevacizumab. The purpose of the current study was to characterize the evolution of these lesions and to determine their relationship...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:AJNR Am J Neuroradiol
Autors principals: Mong, S., Ellingson, B.M., Nghiemphu, P.L., Kim, H.J., Mirsadraei, L., Lai, A., Yong, W., Zaw, T.M., Cloughesy, T.F., Pope, W.B.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Neuroradiology 2012
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7964759/
https://ncbi.nlm.nih.gov/pubmed/22538078
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3174/ajnr.A3053
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!